Osang Healthcare Co.,Ltd
Osang Healthcare Co.,Ltd researches, develops, and sells various diagnostic biosensors in South Korea and internationally. The company offers diagnostic biosensors for blood glucose, hemoglobin A1c, cholesterol, immuno diagnosis, molecular diagnosis, and others. It also exports its products to approximately 110 countries worldwide. The company was formerly known as Infopia Co., Ltd. and changed i… Read more
Osang Healthcare Co.,Ltd (036220) - Total Liabilities
Latest total liabilities as of September 2024: ₩9.84 Billion KRW
Based on the latest financial reports, Osang Healthcare Co.,Ltd (036220) has total liabilities worth ₩9.84 Billion KRW as of September 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Osang Healthcare Co.,Ltd - Total Liabilities Trend (2022–2024)
This chart illustrates how Osang Healthcare Co.,Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Osang Healthcare Co.,Ltd Competitors by Total Liabilities
The table below lists competitors of Osang Healthcare Co.,Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Banestes S.A - Banco do Estado do Espírito Santo
SA:BEES3
|
Brazil | R$36.68 Billion |
|
Vaccibody AS
F:5VB
|
Germany | €6.45 Million |
|
China Everbright Greentech Limited
F:CK7
|
Germany | €25.30 Billion |
|
InspireMD Inc
NASDAQ:NSPR
|
USA | $14.36 Million |
|
Index Living Mall Public Company Limited
BK:ILM
|
Thailand | ฿6.70 Billion |
|
Pinar Sut Mamulleri Sanayi AS
IS:PNSUT
|
Turkey | TL9.48 Billion |
|
Tobii AB
PINK:TBIIF
|
USA | $898.74 Million |
|
Kolon Global Corp
KO:003075
|
Korea | ₩2.10 Trillion |
Liability Composition Analysis (2022–2024)
This chart breaks down Osang Healthcare Co.,Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 8.98 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 3.06 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.04 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.03 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Osang Healthcare Co.,Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Osang Healthcare Co.,Ltd (2022–2024)
The table below shows the annual total liabilities of Osang Healthcare Co.,Ltd from 2022 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩9.25 Billion | -66.38% |
| 2023-12-31 | ₩27.52 Billion | -44.21% |
| 2022-12-31 | ₩49.33 Billion | -- |